Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once Daily for Erectile Dysfunction
NCT00381732Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tadalafil in erectile dysfunction (ED) (3 arms), sponsored by Eli Lilly and Company. Primary endpoints: Changes in erectile function at 24 weeks and Assessment of safety at 2 years. Started Oct 2003; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00381732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381732.